找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Legal Developments on Cybersecurity and Related Fields; Francisco António Carneiro Pacheco de Andrade,Pedr Book 2024 The Editor(s) (if app

[复制链接]
楼主: 无感觉
发表于 2025-3-23 09:58:41 | 显示全部楼层
e towards the religious ‘other’. The authors thus adopt this framework in the book, as a method of categorising people in a diverse society which in turnhelps readers to understand the nuances of Islam and Muslims in a huge country like Indonesia..978-981-97-1142-0978-981-97-1140-6Series ISSN 2522-8730 Series E-ISSN 2522-8749
发表于 2025-3-23 16:09:11 | 显示全部楼层
发表于 2025-3-23 21:41:45 | 显示全部楼层
Alessandra Silveirae towards the religious ‘other’. The authors thus adopt this framework in the book, as a method of categorising people in a diverse society which in turnhelps readers to understand the nuances of Islam and Muslims in a huge country like Indonesia..978-981-97-1142-0978-981-97-1140-6Series ISSN 2522-8730 Series E-ISSN 2522-8749
发表于 2025-3-24 02:08:33 | 显示全部楼层
发表于 2025-3-24 02:51:46 | 显示全部楼层
Pedro Miguel Fernandes Freitasn evolution towards more aggressive histology, mostly diffuse large B-cell lymphoma (DLBCL) occurs in around 10% of cases. Since prospective phase III trials are lacking, the treatment is not standardised. Currently, the aim of treatment is primarily palliative, and outside of a clinical study, it i
发表于 2025-3-24 09:21:51 | 显示全部楼层
发表于 2025-3-24 14:26:13 | 显示全部楼层
Arno R. Lodder,Joeri J. Toetn evolution towards more aggressive histology, mostly diffuse large B-cell lymphoma (DLBCL) occurs in around 10% of cases. Since prospective phase III trials are lacking, the treatment is not standardised. Currently, the aim of treatment is primarily palliative, and outside of a clinical study, it i
发表于 2025-3-24 15:58:59 | 显示全部楼层
Almudena Valiño Cesrige Exposition gegenüber neuen Substanzen ausschlaggebend für die Wahl der Behandlung. Bruton-Tyrosinkinase(BTK)-Inhibitoren und der BCL2(„B-cell lymphoma 2“)-Inhibitor allein oder in Kombination mit Rituximab können in dieser Situation als optimale Therapie für die Mehrzahl der Patienten angesehen
发表于 2025-3-24 21:30:46 | 显示全部楼层
发表于 2025-3-25 00:55:00 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-28 13:11
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表